If you would like to ask our webinar guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund a question please submit them here.

 

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBraime Ord Regulatory News (BMTO)

Share Price Information for Braime Ord (BMTO)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 2,150.00
Bid: 1,900.00
Ask: 2,400.00
Change: 0.00 (0.00%)
Spread: 500.00 (26.316%)
Open: 2,150.00
High: 2,150.00
Low: 2,150.00
Prev. Close: 2,150.00
BMTO Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Half Yearly Report

25 Sep 2013 07:00

RNS Number : 7951O
Braime (T.F.& J.H.) (Hldgs) PLC
25 September 2013
 



 

 

T.F. & J.H. Braime (Holdings) P.L.C.

 

("Braime" or the "Company")

 

INTERIM REPORT

 

FOR THE SIX MONTHS ENDED 30TH JUNE 2013

 

 

Sales revenue for the first six months of 2013 increased by 6% to £11,224,000 (2012: 10,586,601). Profit before tax increased to £391,000 (2012: £258,000) and the profit after tax increased to £266,000 (2012: £179,000) 2012.

 

Although this modest profit remains well below our target, the improvement in profitability is welcome, particularly given the background of the continuing difficult markets.

 

Cash and investments

After previous periods of strong cash generation, the operating cash flow for the first six months of 2013 was negative due primarily to an increase in both stocks and debtors over and above our trade credit finance.

 

The transfer of our banking arrangements in January of this year to HSBC has both reduced our finance costs and strengthened the group's financial position. This enabled the directors to take up the option to purchase, with the assistance of mortgage funding, new and much larger premises in the US which we had moved into in 2012. The timing also enabled the Company to benefit from the `Roll Over` tax relief on the profit arising on the sale of the previous US property. Over and above the mortgage, the purchase resulted in a net outflow of funds of £297,000, although much of this cash requirement came from the sale in 2012 of our previous US property.

 

Dividends

The directors have taken the decision to maintain the first interim dividend at the same level as 2012. A dividend of 2.40p per share will be paid on 9th October to the Ordinary and `A` Ordinary shareholders on the register on 4th October 2013. The associated ex-dividend date will be 2nd October 2013.

 

Performance of group companies

 

4B division

The performance of our distribution businesses was mixed, with some subsidiaries reporting a reduction in profitability. While the result in the US was largely flat, the UK operation enjoyed an improvement. Overall, the operating profitability of the 4B division improved when compared to the first half of 2012. The division is well placed to continue its long term growth.

 

Pressings division

The performance of our manufacturing business in Leeds improved, partly due to a reduction in costs and an increase in sales. We are currently in the midst of a major investment to revise the layout of our facility and introduce a number of new manufacturing cells, including spray painting facilities. We are hopeful of securing substantial increased business with both existing and new customers.

 

Outlook

There have been early signs that the recession may be coming to an end but these signs are both tentative and fragile. We are cautiously optimistic of being able to continue the gradual improvement in profitability but, given the background of relatively weak demand and the continuing volatility in exchange rates, it is difficult to predict the result for 2013.

 

For further information please contact:

 

T.F. & J.H. Braime (Holdings) P.L.C.

O. N. A. Braime - Chairman

 

0113 245 7491

 

W. H. Ireland Limited

Katy Mitchell

0161 832 2174

 

Consolidated income statement

For the six months ended 30th June 2013

 

 

 

 

Note

Unaudited 6 months to 

30th June 2013 

Unaudited 

6 months to 

30th June 2012 

Audited 

year to 31st December 2012 

£ 

£ 

£ 

Revenue

11,224,157 

10,586,601 

21,211,887 

Changes in inventories of finished goods and work in progress

 

356,006 

 

(95,947)

 

(23,484)

Raw materials and consumables used

(6,760,517)

(6,004,802)

(11,849,425)

Employee benefits costs

(2,423,752)

(2,306,180)

(4,587,039)

Depreciation expense

(241,255)

(218,072)

(464,539)

Other expenses

(1,731,995)

(1,671,605)

(3,628,799)

Profit from operations

422,644 

289,995 

658,601 

Profit on disposal of tangible fixed assets

13,239 

5,900 

100,435 

Finance costs

(44,778)

(50,016)

(101,541)

Finance income

274 

12,273 

20,726 

Profit before tax

391,379 

258,152 

678,221 

Tax expense

(125,241)

(79,121)

(251,346)

Profit for the year attributable to equity shareholders of the parent company

 

266,138 

 

179,031 

 

426,875 

Basic and diluted earnings per share

2

18.48p 

12.43p 

29.64p 

 

Consolidated statement of comprehensive income

For the six months ended 30th June 2013

 

Unaudited 

6 months to 

 30th June 

2013 

Unaudited 

6 months to 

30th June 2012 

Audited 

year to 31st December 2012 

£ 

£ 

£ 

Profit for the period

266,138 

179,031 

426,875 

Actuarial losses recognised directly in equity

(7,000)

Foreign exchange losses on re-translation of overseas operations

(24,516)

 

(21,630)

 

(57,608)

Adjustment in respect of minimum funding requirement per IFRIC14

3,000 

10,000 

Total other comprehensive income for the period

(24,516)

(18,630)

(54,608)

Total comprehensive income for the period

241,622 

160,401 

372,267 

 

Consolidated statement of financial position

At 30th June 2013

 

Unaudited

6 months to 

30th June 

2013 

Unaudited 

6 months to 

30th June 

2012 

Audited

year to 31st 

December 

2012 

£ 

£ 

£ 

Non-current assets

Property, plant and equipment

2,531,097 

1,711,300 

1,504,575 

Goodwill

12,270 

12,270 

12,270 

Total non-current assets

2,543,367 

1,723,570 

1,516,845 

Current assets

Inventories

4,794,271 

4,381,296 

4,387,303 

Trade and other receivables

4,597,832 

4,116,516 

3,219,715 

Cash and cash equivalents

637,041 

1,972,761 

1,576,283 

Total current assets

10,029,144 

10,470,573 

9,183,301 

Total assets

12,572,511 

12,194,143 

10,700,146 

Current liabilities

Bank overdraft

392,403 

2,055,431 

642,492 

Trade and other payables

3,221,111 

2,642,811 

2,478,283 

Other financial liabilities

1,285,701 

868,517 

863,922 

Corporation tax liability

119,714 

82 

Total current liabilities

5,018,929 

5,566,841 

3,984,697 

Non-current liabilities

Financial liabilities

1,189,708 

604,596 

515,437 

Total non-current liabilities

1,189,708 

604,596 

515,437 

Total liabilities

6,208,637 

6,171,437 

4,500,134 

Total net assets

6,363,874 

6,022,706 

6,200,012 

Capital and reserves

Share capital

360,000 

360,000 

360,000 

Capital reserve

77,319 

77,319 

77,319 

Foreign exchange reserve

252,635 

313,129 

277,151 

Retained earnings

5,673,920 

5,272,258 

5,485,542 

Total equity attributable to equity shareholders

of the company

 

6,363,874 

 

6,022,706 

 

6,200,012 

 

Consolidated statement of changes in equity

For the six months ended 30th June 2013

 

 

Share Capital 

 

Capital 

Reserve 

Foreign 

Exchange Reserve 

 

Retained 

Earnings 

 

 

Total 

£ 

£ 

£ 

£ 

£ 

Balance at 1st January 2013

360,000 

77,319 

277,151 

5,485,542 

6,200,012 

Comprehensive income

Profit

266,138 

266,138 

Other comprehensive income

Actuarial gains recognised directly in equity

 

 

 

 

 

Foreign exchange losses on re-translation of overseas operations

 

 

 

 

 

 

(24,516)

 

 

 

 

(24,516)

Adjustment in respect of minimum funding requirement per IFRIC14

 

 

 

 

 

 

 

 

 

 

Total other comprehensive income

 

 

 

(24,516)

 

 

(24,516)

Total comprehensive income

(24,516)

266,138 

241,622 

Transaction with owners

Dividends

(77,760)

(77,760)

Total transactions with owners

(77,760)

(77,760)

Balance at 30th June 2013

360,000 

77,319 

252,635 

5,673,920 

6,363,874 

Balance at 1st January 2012

360,000 

77,319 

334,759 

5,167,987 

5,940,065 

Comprehensive income

Profit

179,031 

179,031 

Other comprehensive income

Actuarial gains recognised directly in equity

 

 

 

 

 

Foreign exchange gains on re-translation of overseas operations

 

 

 

 

 

 

(21,630)

 

 

 

 

(21,630)

Adjustment in respect of minimum funding requirement per IFRIC14

 

 

 

 

 

 

 

 

3,000 

 

 

3,000 

Total other comprehensive income

 

-

 

 

(21,630)

 

3,000 

 

(18,630)

Total comprehensive income

(21,630)

182,031 

160,401 

Transaction with owners

Dividends

(77,760)

(77,760)

Total transactions with owners

(77,760)

(77,760)

Balance at 30th June 2012

360,000 

77,319 

313,129 

5,272,258 

6,022,706 

Balance at 1st January 2012

360,000 

77,319 

334,759 

5,167,987 

5,940,065 

Comprehensive income

Profit

426,875 

426,875 

Other comprehensive income

Actuarial losses recognised directly in equity

 

 

 

 

(7,000)

 

(7,000)

Foreign exchange gains on re-translation of overseas operations

 

 

 

 

 

 

(57,608)

 

 

 

 

(57,608)

Adjustment in respect of minimum funding requirement per IFRIC14

 

 

 

 

 

 

 

 

10,000 

 

 

10,000 

Total other comprehensive income

 

 

 

(57,608)

 

3,000 

 

(54,608)

Total comprehensive income

(57,608)

429,875 

372,267 

Transaction with owners

Dividends

(112,320)

(112,320)

Total transactions with owners

(112,320)

(112,320)

Balance at 31st December 2012

360,000 

77,319 

277,151 

5,485,542 

6,200,012 

 

Consolidated cash flow statement

For the six months ended 30th June 2013

 

 

 

 

 

 

Note

Unaudited 

6 months to 

30th June 

2013 

Unaudited 

6 months to 

30th June 

2012 

Audited 

year to 31st December 

2012 

£ 

£ 

£

 

Operating activities

 

Net profit from ordinary activities

266,137 

179,031 

426,875 

 

 

Adjustments for:

 

Depreciation

241,255 

218,073 

464,539 

 

Grants amortised

(828)

(828)

(1,656)

 

Foreign exchange losses

(30,871)

(18,825)

(53,182)

 

Finance income

(274)

(12,273)

(20,726)

 

Finance expense

44,778 

50,016 

101,541 

 

Gain on sale of plant and equipment

(13,239)

(5,900)

(100,435)

 

Adjustment in respect of defined benefit scheme

 

 

13,000 

 

21,000 

 

Income tax expense

125,241 

79,121 

251,346 

 

 

Operating profit before changes in working capital and provisions

 

632,199 

 

501,415 

 

1,089,302 

 

 

(Increase)/decrease in trade and other receivables

(1,378,117)

(609,022)

363,898 

 

(Increase)/decrease in inventories

(406,968)

20,437 

14,430 

 

Increase in trade and other payables

1,084,954 

654,105 

444,808 

 

 

(700,131)

65,520 

823,136 

 

 

Net cash from operating activities

(67,932)

566,935 

1,912,438 

 

 

Income taxes paid

(5,527)

(193,359)

(441,784)

 

 

Investing activities

 

Purchase of property

(1,187,465)

 

Purchases of plant, machinery and motor vehicles

(84,662)

(317,507)

(483,734)

 

Sale of plant, machinery and motor vehicles

13,239 

5,900 

378,440 

 

Interest received

274 

2,273 

2,726 

 

 

(1,258,614)

(309,334)

(102,568)

 

 

Financing activities

 

Proceeds from long term borrowings

890,443 

 

Repayment of borrowings

(6,782)

(173,137)

(247,065)

 

Repayment of hire purchase creditors

(118,203)

(106,706)

(234,076)

 

Interest paid

(44,778)

(50,016)

(101,541)

 

Dividend paid

(77,760)

(77,760)

(112,320)

 

 

642,920 

(407,619)

(695,002)

 

 

 

 

Decrease in cash and cash equivalent

4

(689,153)

(343,377)

673,084 

 

Cash and cash equivalents (including overdrafts), beginning of period

 

4

 

933,791 

 

260,707 

 

260,707 

 

Cash and cash equivalents (including overdrafts), end of period

 

244,638 

 

(82,670)

 

933,791 

 

 

Notes to the interim financial report

 

1. Accounting policies

Basis of preparation

The interim financial report has been prepared using accounting policies that are consistent with those used in the preparation of the full financial statements to 31st December 2012 and those which management expects to apply in the group's full financial statements to 31st December 2013.

 

This interim financial report is unaudited. The comparative financial information set out in this interim financial report does not constitute the group's statutory accounts for the period ended 31st December 2012 but is derived from the accounts. Statutory accounts for the period ended 31st December 2012 have been delivered to the Registrar of Companies. The auditors have reported on those accounts. Their audit report was unqualified and did not contain any statements under Section 498 of the Companies Act 2006.

 

The group's condensed interim financial information has been prepared in accordance with International Financial Reporting Standards ('IFRS') as adopted for the use in the European Union and in accordance with IAS 34 'Interim Financial Reporting' and the accounting policies included in the Annual Report for the year ended 31st December 2012, which have been applied consistently throughout the current and preceding periods.

 

2. Earnings per share and dividends

Both the basic and diluted earnings per share have been calculated using the net results attributable to shareholders of T.F. & J.H. Braime (Holdings) P.L.C. as the numerator.

 

The weighted average number of outstanding shares used for basic earnings per share amounted to 1,440,000 (2012 - 1,440,000). There are no potentially dilutive shares in issue.

 

6 months to 30th June 2013 

£ 

Dividends paid

Equity shares

Ordinary shares

Interim of 5.40p per share paid on 4th April 2013

25,920 

'A' Ordinary shares

Interim of 5.40p per share paid on 4th April 2013

51,840 

Total dividends paid

77,760 

Year to 31st 

December 

2012 

£ 

Dividends paid

Equity shares

Ordinary shares

Interim of 5.40p per share paid on 2nd April 2012

25,920 

Interim of 2.40p per share paid on 10th October 2012

11,520 

37,440 

'A' Ordinary shares

Interim of 5.40p per share paid on 2nd April 2012

51,840 

Interim of 2.40p per share paid on 10th October 2012

23,040 

74,880 

Total dividends paid

112,320 

 

3. Amendment to comparative figures

Following changes to IAS 19, defined benefit interest costs have been offset against the expected return on scheme assets disclosed within the consolidated income statement. As a consequence of this change in treatment the comparative figures for finance expenses and income have been reduced by the value of the defined benefit interest cost of £132,000.

 

4. Cash and cash equivalents

 Unaudited 

6 months to 

30th June 

2013 

Unaudited 

6 months to 

30th June 

2012 

Audited 

year to 31st 

December 

2012 

£ 

£ 

£ 

Cash at bank and in hand

637,041 

1,972,761 

1,576,283 

Bank overdrafts

392,403 

2,055,431 

642,492 

244,638 

(82,670)

933,791 

 

 

5. Segmental information

Unaudited 6 months to 30th June 2013 

Central 

Manufacturing

Distribution 

Total 

£ 

£ 

£ 

£ 

Revenue

External

1,682,274 

9,541,883 

11,224,157 

Inter company

20,000 

1,306,284 

1,300,717 

2,627,001 

Total

20,000 

2,988,558 

10,842,600 

13,851,158 

Profit

EBITDA

(45,532)

112,694 

609,976 

677,138 

Finance costs

(9,399)

(18,722)

(16,657)

(44,778)

Finance income

201 

73 

274 

Depreciation

(167,697)

(73,558)

(241,255)

Tax expense

(5,200)

(120,041)

(125,241)

(Loss)/profit for the period

(59,930)

(73,725)

399,793 

266,138 

Assets

Total assets

1,214,383 

2,232,335 

9,125,793 

12,572,511 

Additions to non current assets

1,187,465 

31,406 

53,256 

1,272,127 

Liabilities

Total liabilities

492,760 

1,676,445 

4,039,432 

6,208,637 

 

Unaudited 6 months to 30th June 2012 

Central 

Manufacturing

Distribution 

Total 

£ 

£ 

£ 

£ 

Revenue

External

1,381,341 

9,205,260 

10,586,601 

Inter company

31,074 

1,511,451 

857,751 

2,400,276 

Total

31,074 

2,892,792 

10,063,011 

12,986,877 

Profit

EBITDA

(10,807)

(6,128)

530,903 

513,968 

Finance costs

(6,913)

(156,718)

(18,385)

(182,016)

Finance income

728 

143,475 

70 

144,273 

Depreciation

(173,700)

(44,373)

(218,073)

Tax expense

(11,227)

(67,894)

(79,121)

(Loss)/profit for the period

(28,219)

(193,071)

400,321 

179,031 

Assets

Total assets

617,155 

3,061,128 

8,515,860 

12,194,143 

Additions to non current assets

317,486 

185,611 

503,097 

Liabilities

Total liabilities

463,698 

2,513,622 

3,194,117 

6,171,437 

 

 

Audited year to 31st December 2012 

 

Central 

Manufacturing

Distribution 

Total 

£ 

£ 

£ 

£ 

Revenue

External

2,992,202 

18,219,685 

21,211,887 

Inter company

51,390 

3,339,322 

2,300,456 

5,691,168 

Total

51,390 

6,331,524 

20,520,141 

26,903,055 

Profit

EBITDA

(20,799)

253,679 

896,659 

1,129,539 

Gain on sale of land & buildings

94,036 

94,036 

Finance costs

(11,302)

(49,488)

(40,751)

(101,541)

Finance income

1,105 

19,505 

116 

20,726 

Depreciation

(331,640)

(132,899)

(464,539)

Tax expense

(17,718)

(233,628)

(251,346)

(Loss)/profit for the period

45,322 

(107,944)

489,497 

426,875 

Assets

Total assets

625,569 

2,250,827 

7,823,750 

10,700,146 

Additions to non current assets

439,004 

385,546 

824,550 

Liabilities

Total liabilities

458,973 

1,670,820 

2,370,341 

4,500,134 

 

 

24th September 2013

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IR GMGZLKDGGFZM
12
Date   Source Headline
22nd Apr 20247:00 amRNSANNUAL RESULTS YEAR ENDED 31ST DECEMBER 2023
4th Sep 20234:34 pmRNSInterim Results
23rd Jun 202312:41 pmRNSResult of AGM
24th Apr 202310:03 amRNSAnnual Results for the Year Ended 31 December 2022
19th Apr 20235:39 pmRNSDirectorate Changes
30th Jan 202311:26 amRNSBoard Changes
5th Sep 202212:20 pmRNSInterim Results for Six Months Ended 30 June 2022
24th Jun 20227:00 amRNSResults of Annual General Meeting
22nd Jun 20227:00 amRNSChain Cell Project Update
28th Apr 20227:00 amRNSAnnual Results for the Year Ended 31 December 2021
24th Feb 20227:00 amRNSWarehouse Update
8th Sep 20214:04 pmRNSInterim Results for six months ended 30 June 2021
18th Aug 20213:31 pmRNSLoan Agreement
25th Jun 20215:23 pmRNSResult of AGM
16th Jun 202112:07 pmRNSUpdate on AGM Arrangements
4th May 202111:36 amRNSDividend Update
27th Apr 20214:29 pmRNSAnnual Results for the year ended 31 December 2020
18th Sep 20207:00 amRNSInterim Results for the period to 30 June 2020
1st Jul 20202:01 pmRNSAnnual General Meeting
12th May 202010:00 amRNSAnnual Results for the year ended 31 Dec 2019
30th Jan 20207:00 amRNSUpdate
9th Dec 20194:15 pmRNSDirector Declaration
19th Sep 201912:10 pmRNSInterim Results for the six months ended 30 Jun 19
14th Aug 20197:00 amRNSChange of Name
1st Aug 20195:20 pmRNSResult of General Meeting
28th Jun 20199:00 amRNSShareholder Notification
29th Apr 20197:00 amRNSAnnual Results for year ended 31 December 2018
21st Sep 20187:00 amRNSInterim Results - six months ended 30th June 2018
2nd May 20187:00 amRNSAnnual Results
1st May 20187:00 amRNSDirector Appointment
11th Dec 20177:00 amRNSDirector-Designate Appointment
5th Oct 201712:33 pmRNSDirector Resignation
19th Sep 20174:11 pmRNSHalf-year Report
12th Jul 201711:08 amRNSShareholder Notification
26th Apr 201711:49 amRNSFinal Results
1st Dec 201611:43 amRNSDirector Appointment
27th Sep 20167:00 amRNSHalf-year Report
28th Jun 20167:00 amRNSDirector Appointment
13th May 20163:48 pmRNSHolding(s) in Company
22nd Apr 20167:00 amRNSFinal Results
15th Apr 20167:00 amRNSDividend Declaration
12th Feb 20167:00 amRNSUpdate on Board Changes
4th Dec 20153:11 pmRNSDirectorate Change
19th Oct 20152:09 pmRNSDisposal
22nd Sep 20152:59 pmRNSHalf Yearly Report
4th Jun 20159:55 amRNSTR-1: Notification of Major Interest in Shares
21st Apr 20159:32 amRNSFinal Results
16th Apr 20157:00 amRNSConditional Disposal
13th Mar 201510:14 amRNSDividend Declaration
18th Dec 201411:41 amRNSCancellation of Cumulative Preference Shares
12

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.